Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

616452 TGF-β RI Kinase Inhibitor II - CAS 446859-33-2 - Calbiochem

616452
Purchase on Sigma-Aldrich

Áttekintés

Replacement Information

Kulcsspecifikációk táblázata

CAS #Empirical Formula
446859-33-2C₁₇H₁₃N₅

Products

KatalógusszámCsomagolás Menny./csomag
616452-2MG Üvegpalack 2 mg
Description
OverviewA cell-permeable naphthyridinyl pyrazolo compound that acts as a potent, selective, reversible, and ATP-competitive inhibitor of TGF-β type I receptor (ALK5; IC50 = 23 nM, 4 nM and 18 nM for ALK5 binding, ALK5 auto-phosphorylation and TGF-β cellular assay in HepG2 cells, respectively). Minimally affects a panel of 9 closely related kinases including p38 MAPK at IC50 > 16 µM. Also available as a 50 mM solution in DMSO (Cat. No. 508158).
Catalogue Number616452
Brand Family Calbiochem®
SynonymsALK5 Inhibitor II, Transforming Growth Factor-β Type I Receptor Kinase Inhibitor II, 2-(3-(6-Methylpyridin-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine
References
ReferencesGellibert, F., et al. 2004. J. Med. Chem. 47, 4494.
Ichida, J. K., et al. 2009. 5, 491.
Product Information
CAS number446859-33-2
ATP CompetitiveY
FormYellow solid
Hill FormulaC₁₇H₁₃N₅
Chemical formulaC₁₇H₁₃N₅
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
Biological Information
Primary TargetALKS binding
Primary Target IC<sub>50</sub>23 nM
Secondary targetALK 5 auto phosphorylation (IC₅₀ = 4 nM)
Purity≥95% by HPLC
Physicochemical Information
Cell permeableY
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Standard Handling
Storage +2°C to +8°C
Protect from Light Protect from light
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Katalógusszám GTIN
616452-2MG 04055977185829

Documentation

TGF-β RI Kinase Inhibitor II - CAS 446859-33-2 - Calbiochem MSDS

Title

Safety Data Sheet (SDS) 

TGF-β RI Kinase Inhibitor II - CAS 446859-33-2 - Calbiochem Certificates of Analysis

TitleLot Number
616452

References

Hivatkozások áttekintése
Gellibert, F., et al. 2004. J. Med. Chem. 47, 4494.
Ichida, J. K., et al. 2009. 5, 491.

Data Sheet

Title
Reprogramming Cell Fate and Function Novel Strategies for iPSC Generation, Characterization, and Differentiation

Citations

Titulus
Maherali N., and Hochedlinger, K., 2009. Current Biology 19, 1718.
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision19-April-2011 RFH
SynonymsALK5 Inhibitor II, Transforming Growth Factor-β Type I Receptor Kinase Inhibitor II, 2-(3-(6-Methylpyridin-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine
DescriptionA cell-permeable, potent, selective, reversible, and ATP-competitive inhibitor of TGF-β type I receptor (ALK5; IC50 = 23 nM, 4 nM and 18 nM for ALK5 binding, ALK5 auto-phosphorylation, and TGF-β cellular assay in HepG2 cells, respectively). Minimally affects a panel of 9 closely related kinases including p38 MAPK (IC50 >16 µM).
FormYellow solid
Intert gas (Yes/No) Packaged under inert gas
CAS number446859-33-2
Chemical formulaC₁₇H₁₃N₅
Structure formulaStructure formula
Purity≥95% by HPLC
SolubilityDMSO (5 mg/ml) or Methanol (5 mg/ml)
Storage Protect from light
+2°C to +8°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Toxicity Standard Handling
ReferencesGellibert, F., et al. 2004. J. Med. Chem. 47, 4494.
Ichida, J. K., et al. 2009. 5, 491.
CitationMaherali N., and Hochedlinger, K., 2009. Current Biology 19, 1718.